A. Olympitis

A. Olympitis

Auto-generated profile, based on publicly available information

A. Olympitis

Division of Cancer Sciences, The University of Manchester, The Christie Hospital NHS Foundation Trust, Manchester M20 4GJ, UK

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2025 in bioRxiv
Verified
Preprint
Open access
CQConrado Guerrero Quiles
Conrado Guerrero Quiles
AGA. Julia Gonzalez
A. Julia Gonzalez
AFA. S. Foussat
A. S. Foussat
AOA. Olympitis
A. Olympitis
TLT. Lodhi
T. Lodhi
CWCatharine Mary Louise West
Catharine Mary Louise West
Our overarching aim was to determine how hypoxia affects the extracellular matrix (ECM). Transcriptomic analysis (21,941 patients; 10 cancer types) identified ECM remodelling as the predominant pathway affected by hypoxia. Multi-omics confirmed that hypoxia impacts ECM organisation and collagen degradation; 53 ECM genes were affected, of which 74% were HIF1/HIF2-regulated. Spatial transcriptomics highlighted different hypoxia remodelling processes in tumour and stroma. Five ECM genes commonly affected in tumour and in vitro constituted a signature. This signature was independently prognostic and independently predictive of radiotherapy benefit in multiple malignancies. Patients within either high or low hypoxic-ECM score tertiles benefited from radiotherapy versus surgery. Hypoxic ECMs generated in vitro increased adhesion and decreased migration of cancer cells, an effect enhanced by irradiation. Immunofluorescence demonstrated that hypoxia decreased collagen fibre number, and irradiation decreased cell-ECM interactions. Taken together, these findings demonstrate hypoxia induces pan-cancer ECM changes, directly impacting radiotherapy benefit.